R. Bravo

778 citations
14 papers · 357 indexed · h-index 8

R. Bravo

14 papers receiving 339 citations

Peers

R. Bravo
Comparison fields: 5 of 43
  • Hepatology 293
  • Epidemiology 261
  • Infectious Diseases 124
  • Virology 30
  • Immunology 25
Replace F. Mazzotta with:
F. Mazzotta Italy
Xiomara V. Thomas Netherlands
S Tanprasert Thailand
Yasunobu Kawakami Japan
I. K. Kuramoto United States
Emma Page United Kingdom
Mukomolov Sl Russia
M.H. Elghouzzi France
Giuseppina Cappiello Italy
Jeffrey C. Hunt United States
R. Bravo relative to F. Mazzotta Italy F. Mazzotta's profile →
Citations per field
00.5×1.5×2.1×
F. Mazzotta · 1×
Citations per year

Countries citing papers authored by R. Bravo

Since Specialization
Citations

This map shows the geographic impact of R. Bravo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Bravo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Bravo more than expected).

Fields of papers citing papers by R. Bravo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Bravo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Bravo. The network helps show where R. Bravo may publish in the future.

Co-authorship network of co-authors of R. Bravo

This figure shows the co-authorship network connecting the top 25 collaborators of R. Bravo. A scholar is included among the top collaborators of R. Bravo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Bravo. R. Bravo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 15
2
Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.
114
3 11
4
[The treatment of chronic hepatitis C with interferon in patients infected with the human immunodeficiency virus. The Spanish Group for the Study of Viral Hepatitis in HIV+ Patients].
2
5 145
6
[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid].
5
7
[Prevalence of the genotypes of the hepatitis C virus in Spanish drug addicts with chronic hepatitis C. Spanish Group for the Study of Viral Hepatitis in HIV Positive Patients].
7
8 5
9
[Report of the first 2 cases of HIV-1 group O infection in Spain].
5
10 25
11 12
12 1
13
[Morbidity and mortality associated with chronic viral hepatopathy in patients infected with the human immunodeficiency virus].
7
14
Fibroblast-induced cytokine (fic) and monocyte chemoattractant peptide-2 (mcp-2), 2 new beta-chemokines, cause basophil histamine-release
3

About R. Bravo

R. Bravo is a scholar working on Hepatology, Virology and Epidemiology, having authored 14 papers that have together received 357 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Hepatitis C virus research (7 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Hepatology (293 citations), Epidemiology (261 citations) and Infectious Diseases (124 citations). R. Bravo has collaborated with scholars based in Spain, United States and Guatemala. Frequent co-authors include Vincent Soriano, Javier García‐Samaniego, Jesús Castilla, Alena Mayo Iñiguez, F Muñoz, Jorge Carbó, Jorge González, Juan González‐Lahoz, Á. Castro and E. Carballo. Their work appears in journals such as Clinical Infectious Diseases, Journal of Allergy and Clinical Immunology and Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026